Suppr超能文献

优化的分段放疗联合抗 PD-L1 和抗 TIGIT:一种有前途的新组合。

Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination.

机构信息

Department of Radiation Oncology, Unicancer - Georges-Francois Leclerc Cancer Center, 1 rue Professeur Marion 77 980, 21079, Dijon Cedex, BP, France.

Cancer Biology Research Platform, Unicancer - Georges-Francois Leclerc Cancer Center, Dijon, France.

出版信息

J Immunother Cancer. 2019 Jun 25;7(1):160. doi: 10.1186/s40425-019-0634-9.

Abstract

PURPOSE/OBJECTIVE: Radiotherapy (RT) induces an immunogenic antitumor response, but also some immunosuppressive barriers. It remains unclear how different fractionation protocols can modulate the immune microenvironment. Clinical studies are ongoing to evaluate immune checkpoint inhibitors (ICI) in association with RT. However, only few trials aim to optimize the RT fractionation to improve efficacy of these associations. Here we sought to characterize the effect of different fractionation protocols on immune response with a view to associating them with ICI.

MATERIALS/METHODS: Mice bearing subcutaneous CT26 colon tumors were irradiated using a SARRP device according to different radiation schemes with a same biologically effective dose. Mice were monitored for tumor growth. The radiation immune response (lymphoid, myeloid cells, lymphoid cytokines and immune checkpoint targets) was monitored by flow cytometry at different timepoints after treatment and by RNA sequencing analysis (RNAseq). The same radiation protocols were performed with and without inhibitors of immune checkpoints modulated by RT.

RESULTS

In the absence of ICI, we showed that 18x2Gy and 3x8Gy induced the longest tumor growth delay compared to 1×16.4Gy. While 3x8Gy and 1×16.4Gy induced a lymphoid response (CD8 T-cells, Regulators T-cells), 18x2Gy induced a myeloid response (myeloid-derived suppressor cells, tumor-associated macrophages 2). The secretion of granzyme B by CD8 T cells was increased to a greater extent with 3x8Gy. The expression of PD-L1 by tumor cells was moderately increased by RT, but most durably with 18x2Gy. T cell immunoreceptor with Ig and ITIM domains (TIGIT) expression by CD8 T-cells was increased with 3x8Gy, but decreased with 18x2Gy. These results were also observed with RNAseq. RT was dramatically more effective with 3x8Gy compared to all the other treatments schemes when associated with anti-TIGIT and anti-PD-L1 (9/10 mice in complete response). The association of anti-PD-L1 and RT was also effective in the 18x2Gy group (8/12 mice in complete response).

CONCLUSION

Each fractionation scheme induced different lymphoid and myeloid responses as well as various modulations of PD-L1 and TIGIT expression. Furthermore, 3x8Gy was the most effective protocol when associated with anti-PD-L1 and anti-TIGIT. This is the first study combining RT and anti-TIGIT with promising results; further studies are warranted.

摘要

目的/目标:放射治疗(RT)会引发抗肿瘤的免疫反应,但也会产生一些免疫抑制屏障。不同分割方案如何调节免疫微环境仍不清楚。目前正在进行临床研究,以评估免疫检查点抑制剂(ICI)与 RT 联合应用。然而,只有少数试验旨在优化 RT 分割以提高这些联合治疗的疗效。在这里,我们试图描述不同分割方案对免疫反应的影响,以期将其与 ICI 联合应用。

材料/方法:将皮下 CT26 结肠肿瘤的小鼠使用 SARRP 设备按照不同的放射方案进行照射,这些方案具有相同的生物有效剂量。监测小鼠的肿瘤生长情况。通过流式细胞术在治疗后不同时间点以及通过 RNA 测序分析(RNAseq)监测放射免疫反应(淋巴细胞、髓样细胞、淋巴细胞细胞因子和免疫检查点靶标)。使用和不使用 RT 调节的免疫检查点抑制剂,对相同的放射方案进行了测试。

结果

在没有 ICI 的情况下,我们发现与 1×16.4Gy 相比,18×2Gy 和 3×8Gy 诱导的肿瘤生长延迟时间最长。虽然 3×8Gy 和 1×16.4Gy 诱导了淋巴细胞反应(CD8 T 细胞、调节性 T 细胞),但 18×2Gy 诱导了髓样细胞反应(髓源性抑制细胞、肿瘤相关巨噬细胞 2)。CD8 T 细胞分泌的颗粒酶 B 增加的程度随 3×8Gy 而增加。肿瘤细胞 PD-L1 的表达通过 RT 适度增加,但通过 18×2Gy 增加最持久。CD8 T 细胞上的 T 细胞免疫受体 Ig 和 ITIM 结构域(TIGIT)表达随 3×8Gy 增加,但随 18×2Gy 减少。这些结果也通过 RNAseq 观察到。与所有其他治疗方案相比,当与抗 TIGIT 和抗 PD-L1 联合应用时,3×8Gy 的放射治疗效果显著更好(10/10 只小鼠完全缓解)。抗 PD-L1 和 RT 联合治疗在 18×2Gy 组也有效(12/12 只小鼠完全缓解)。

结论

每种分割方案都诱导了不同的淋巴细胞和髓样细胞反应,以及 PD-L1 和 TIGIT 表达的不同调节。此外,当与抗 PD-L1 和抗 TIGIT 联合应用时,3×8Gy 是最有效的方案。这是首次结合 RT 和抗 TIGIT 的研究,结果令人鼓舞;需要进一步的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a367/6593525/c1c7dda5e532/40425_2019_634_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验